Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia.

Leukemia - 1 Nov 2020

Wander Priscilla, Cheung Laurence C, Pinhanҫos Sandra S, Jones Luke, Kerstjens Mark, Arentsen-Peters Susan T C J M, Singh Sajla, Chua Grace-Alyssa, Castro Patricia Garrido, Schneider Pauline, Dolman M Emmy M, Koopmans Bianca, Molenaar Jan J, Pieters Rob, Zwaan C Michel, Kotecha Rishi S, Stam Ronald W

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Deoxycytidine
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Evaluation, Preclinical

Share to Gemcitabine

Share to Gene Rearrangement

Share to Myeloid-Lymphoid Leukemia Protein

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Source

Identifiers

PMID: 32488115
DOI: 10.1038/s41375-020-0895-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia.PMID 32488115Read ↗

Effective Targeting of the P53–MDM2 Axis in Preclinical Models of Infant MLL -Rearranged Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Towards targeted therapy for infant acute lymphoblastic leukaemia.Semantic proximity Read ↗

Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

MLL-rearranged infant leukaemia: A ‘thorn in the side’ of a remarkable success storySemantic proximity Read ↗

Multidrug resistance in pediatric oncologySemantic proximity Read ↗

Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study GroupSemantic proximity Read ↗

Olverembatinib Treatment in Pediatric Patients With Relapsed Philadelphia-Chromosome-Positive Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangementsSemantic proximity Read ↗

Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.Semantic proximity Read ↗

MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations.Semantic proximity Read ↗

Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantationSemantic proximity Read ↗

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.